Follow the Filings · Data · ANIX · Form 4
SEC Form 4 · ANIX · filed Sep 28, 2026

ANIX: director bought $13,800 of Anixa Biosciences Inc

The filing shows 1 Table I transaction by a director of Anixa Biosciences Inc: bought $13,800. Source document and our reading of it are below; the SEC filing is the record, this page is the index.

Freshness

08:30:18SEC acceptance (ET) · Sep 28, 2026
08:30:50first seen by FTF (ET) · SEC current-filings feed
0 min 32 sacceptance → first seen

UTC: accepted 2026-09-28T12:30:18Z · seen 2026-09-28T12:30:50Z. Measured per filing; the distribution for every day is on coverage.

What the filing shows (Table I)

Trade dateCodeSharesPriceValueOwned after
Sep 24, 2026P · Open-market or private purchase5,000$2.76$13,800140,572
Reporting person
Baskies Arnold M · Director
Issuer
Anixa Biosciences Inc · CIK 715446
Accession
0001493152-26-044457
Source
SEC filing index · complete submission
Rule 10b5-1
checkbox not captured by our parser yet — check the filing

Checks

Cluster buyPrice check: consistent

filing price is 0.99× the 2026-09-24 close (close $2.78 on 2026-09-24). Band: filing price within 0.4–2.5× of the last market close on or before the trade date; a filing outside the band is not published. Rows dropped by our data checks (duplicates, superseded amendments, impossible values, bulk program events, price outside the band) are excluded from every number on this page.

ANIX insider flow — 30 days to this filing

$214,517open-market buys · 6 rows · 3 insiders
$0open-market sells · 0 rows · 0 insiders
+$214,517net open-market flow
Cluster buy — 3 distinct insiders, $214,517 of open-market purchases between Sep 10, 2026 and Sep 24, 2026.
Definition: 3 or more distinct insiders reported open-market purchases within a 10-trading-day window, and the net open-market flow over the whole period shown is positive. The label is data, not a judgement.
FiledReporting personCodesRowsBuysSellsFiling
Sep 11, 2026KUMAR AMIT · Chief Executive OfficerP1$13,800—0001493152-26-042302
Sep 14, 2026Titterton Lewis H jr · DirectorP1$27,300—0001493152-26-042502
Sep 14, 2026KUMAR AMIT · Chief Executive OfficerP1$8,250—0001493152-26-042512
Sep 25, 2026Titterton Lewis H jr · DirectorP1$131,907—0001493152-26-044250
Sep 28, 2026Baskies Arnold M · DirectorP1$13,800—0001493152-26-044457 (this filing)
Sep 28, 2026KUMAR AMIT · Chief Executive OfficerP1$19,460—0001493152-26-044458

Reading

The most ordinary reading of several insiders buying in the same window is directors and officers adding to holdings in an open trading window, often after results are public. Form 4 does not state a reason, and this page does not infer one.

Scope: SEC Form 4, Table I (non-derivative) only — Table II (options, RSUs) is not shown; on multi-owner filings the first reporting owner; Senate PTRs are covered, House is not. Every filing is reconciled daily against EDGAR's own index — see coverage.
Generated 2026-09-28 12:46 UTC from our reconciled ledger. Amended filings (Form 4/A) replace this page with a notice, they do not delete it. Found an error? hello@followthefilings.io.